Abstract
Whole-genome sequencing of 616 asymptomatically carried Streptococcus pneumoniae isolates was used to study the impact of the 7-valent pneumococcal conjugate vaccine. Comparison of closely related isolates showed the role of transformation in facilitating capsule switching to non-vaccine serotypes and the emergence of drug resistance. However, such recombination was found to occur at significantly different rates across the species, and the evolution of the population was primarily driven by changes in the frequency of distinct genotypes extant before the introduction of the vaccine. These alterations resulted in little overall effect on accessory genome composition at the population level, contrasting with the decrease in pneumococcal disease rates after the vaccine's introduction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Weinberger, D.M. et al. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog. 5, e1000476 (2009).
Whitney, C.G. et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348, 1737–1746 (2003).
Steenhoff, A.P., Shah, S.S., Ratner, A.J., Patil, S.M. & McGowan, K.L. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. Clin. Infect. Dis. 42, 907–914 (2006).
Hicks, L.A. et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J. Infect. Dis. 196, 1346–1354 (2007).
Pai, R. et al. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J. Infect. Dis. 192, 1988–1995 (2005).
Pelton, S.I. et al. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 26, 468–472 (2007).
Finkelstein, J.A. et al. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics 112, 862–869 (2003).
Huang, S.S. et al. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116, e408–e413 (2005).
Huang, S.S. et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 124, e1–e11 (2009).
Hsu, K., Pelton, S., Karumuri, S., Heisey-Grove, D. & Klein, J. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Pediatr. Infect. Dis. J. 24, 17–23 (2005).
Yildirim, I. et al. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine 29, 283–288 (2010).
Yildirim, I., Stevenson, A., Hsu, K.K. & Pelton, S.I. Evolving picture of invasive pneumococcal disease in Massachusetts children: a comparison of disease in 2007–2009 with earlier periods. Pediatr. Infect. Dis. J. 31, 1018–1021 (2012).
Hanage, W.P. et al. Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination. Vaccine 29, 8877–8881 (2011).
Hanage, W.P. et al. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J. Infect. Dis. 195, 347–352 (2007).
McGee, L. et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J. Clin. Microbiol. 39, 2565–2571 (2001).
Atwood, K.C., Schneider, L.K. & Ryan, F.J. Periodic selection in Escherichia coli. Proc. Natl. Acad. Sci. USA 37, 146–155 (1951).
Moore, M.R. et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J. Infect. Dis. 197, 1016–1027 (2008).
Wyres, K.L. et al. Pneumococcal capsular switching: a historical perspective. J. Infect. Dis. 207, 439–449 (2013).
Donati, C. et al. Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species. Genome Biol. 11, R107 (2010).
Hanage, W.P. et al. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics 2, 80–84 (2010).
Hanage, W.P. et al. Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching. Pediatr. Infect. Dis. J. 30, 302–308 (2011).
Hanage, W.P., Kaijalainen, T., Saukkoriipi, A., Rickcord, J.L. & Spratt, B.G. A successful, diverse disease-associated lineage of nontypeable pneumococci that has lost the capsular biosynthesis locus. J. Clin. Microbiol. 44, 743–749 (2006).
Croucher, N.J. et al. Rapid pneumococcal evolution in response to clinical interventions. Science 331, 430–434 (2011).
Park, I.H. et al. Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J. Infect. Dis. 198, 1818–1822 (2008).
Bentley, S.D. et al. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet. 2, e31 (2006).
Gherardi, G., Whitney, C.G., Facklam, R.R. & Beall, B. Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J. Infect. Dis. 181, 216–229 (2000).
Whitney, C.G. et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343, 1917–1924 (2000).
Greene, S.K. et al. Trends in antibiotic use in Massachusetts children, 2000–2009. Pediatrics 130, 15–22 (2012).
Franke, A.E. & Clewell, D.B. Evidence for conjugal transfer of a Streptococcus faecalis transposon (Tn916) from a chromosomal site in the absence of plasmid DNA. Cold Spring Harb. Symp. Quant. Biol. 45, 77–80 (1981).
Shaw, J.H. & Clewell, D.B. Complete nucleotide sequence of macrolide-lincosamide-streptogramin B-resistance transposon Tn917 in Streptococcus faecalis. J. Bacteriol. 164, 782–796 (1985).
Del Grosso, M., Camilli, R., Iannelli, F., Pozzi, G. & Pantosti, A. The mef(E)-carrying genetic element (mega) of Streptococcus pneumoniae: insertion sites and association with other genetic elements. Antimicrob. Agents Chemother. 50, 3361–3366 (2006).
Hakenbeck, R., Tarpay, M. & Tomasz, A. Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 17, 364–371 (1980).
Cavalieri, S. Manual of Antimicrobial Susceptibility Testing (American Society for Microbiology, Washington, D.C., 2005).
Barocchi, M.A. et al. A pneumococcal pilus influences virulence and host inflammatory responses. Proc. Natl. Acad. Sci. USA 103, 2857–2862 (2006).
Regev-Yochay, G. et al. Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. Vaccine 28, 4842–4846 (2010).
Paterson, G.K., Nieminen, L., Jefferies, J.M. & Mitchell, T.J. PclA, a pneumococcal collagen-like protein with selected strain distribution, contributes to adherence and invasion of host cells. FEMS Microbiol. Lett. 285, 170–176 (2008).
Hyde, T.B. et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. J. Am. Med. Assoc. 286, 1857–1862 (2001).
Kyaw, M.H. et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. 354, 1455–1463 (2006).
Zerbino, D.R. & Birney, E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 18, 821–829 (2008).
Delcher, A.L., Bratke, K.A., Powers, E.C. & Salzberg, S.L. Identifying bacterial genes and endosymbiont DNA with Glimmer. Bioinformatics 23, 673–679 (2007).
Hyatt, D. et al. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics 11, 119 (2010).
Croucher, N.J. et al. Role of conjugative elements in the evolution of the multidrug-resistant pandemic clone Streptococcus pneumoniaeSpain23F ST81. J. Bacteriol. 191, 1480–1489 (2009).
Kent, W.J. BLAT—the BLAST-like alignment tool. Genome Res. 12, 656–664 (2002).
Kristensen, D.M. et al. A low-polynomial algorithm for assembling clusters of orthologous groups from intergenomic symmetric best matches. Bioinformatics 26, 1481–1487 (2010).
Tatusov, R.L., Galperin, M.Y., Natale, D.A. & Koonin, E.V. The COG database: a tool for genome-scale analysis of protein functions and evolution. Nucleic Acids Res. 28, 33–36 (2000).
Edgar, R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792–1797 (2004).
Marttinen, P. et al. Detection of recombination events in bacterial genomes from large population samples. Nucleic Acids Res. 40, e6 (2012).
Stamatakis, A., Ludwig, T. & Meier, H. RAxML-III: a fast program for maximum likelihood–based inference of large phylogenetic trees. Bioinformatics 21, 456–463 (2005).
Tang, J., Hanage, W.P., Fraser, C. & Corander, J. Identifying currents in the gene pool for bacterial populations using an integrative approach. PLoS Comput. Biol. 5, e1000455 (2009).
Simpson, J.T. & Durbin, R. Efficient construction of an assembly string graph using the FM-index. Bioinformatics 26, i367–i373 (2010).
Argueso, J.L. et al. Genome structure of a Saccharomyces cerevisiae strain widely used in bioethanol production. Genome Res. 19, 2258–2270 (2009).
Boetzer, M., Henkel, C.V., Jansen, H.J., Butler, D. & Pirovano, W. Scaffolding pre-assembled contigs using SSPACE. Bioinformatics 27, 578–579 (2011).
Carver, T. et al. Artemis and ACT: viewing, annotating and comparing sequences stored in a relational database. Bioinformatics 24, 2672–2676 (2008).
Harris, S.R. et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 327, 469–474 (2010).
Croucher, N.J., Harris, S.R., Barquist, L., Parkhill, J. & Bentley, S.D. A high-resolution view of genome-wide pneumococcal transformation. PLoS Pathog. 8, e1002745 (2012).
Drummond, A.J., Suchard, M.A., Xie, D. & Rambaut, A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol. Biol. Evol. 29, 1969–1973 (2012).
Drummond, A.J., Ho, S.Y., Phillips, M.J. & Rambaut, A. Relaxed phylogenetics and dating with confidence. PLoS Biol. 4, e88 (2006).
Drummond, A.J., Rambaut, A., Shapiro, B. & Pybus, O.G. Bayesian coalescent inference of past population dynamics from molecular sequences. Mol. Biol. Evol. 22, 1185–1192 (2005).
Stajich, J.E. et al. The Bioperl toolkit: Perl modules for the life sciences. Genome Res. 12, 1611–1618 (2002).
R Core Development Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, 2011).
Acknowledgements
N.J.C. is funded by an AX A postdoctoral fellow award. Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (NIH) under award R01AI066304 and by Wellcome Trust grant 098051. We acknowledge the support of the Sanger Institute core sequencing and informatics teams and productive discussions at PERMAFROST workshops. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US NIH.
Author information
Authors and Affiliations
Contributions
M.L. and W.P.H. conceived the project. M.L., W.P.H., S.D.B., J.P. and J.A.F. supervised the project. N.J.C. and P.K.M. analyzed the data. S.I.P. and G.M.L. helped with interpretation of the data. All authors contributed to writing the manuscript.
Corresponding author
Ethics declarations
Competing interests
S.I.P. has investigator-initiated grants from Merck and Pfizer and has consulted for GlaxoSmithKline, Merck, Pfizer and Novartis. W.P.H. has consulted for GlaxoSmithKline. M.L. has consulted for Pfizer and Novartis.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–29, Supplementary Table 2 (PDF 3703 kb)
Supplementary Table 1
Epidemiological data associated with isolates and accession codes associated with data deposited in the European Nucleotide Archive (XLSX 130 kb)
Rights and permissions
About this article
Cite this article
Croucher, N., Finkelstein, J., Pelton, S. et al. Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet 45, 656–663 (2013). https://doi.org/10.1038/ng.2625
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.2625
This article is cited by
-
Genomic and panproteomic analysis of the development of infant immune responses to antigenically-diverse pneumococci
Nature Communications (2024)
-
A bacterial pan-genome makes gene essentiality strain-dependent and evolvable
Nature Microbiology (2022)
-
Pneumococcal within-host diversity during colonization, transmission and treatment
Nature Microbiology (2022)
-
Global genomic pathogen surveillance to inform vaccine strategies: a decade-long expedition in pneumococcal genomics
Genome Medicine (2021)
-
Whole genomic comparative analysis of Streptococcus pneumoniae serotype 1 isolates causing invasive and non-invasive infections among children under 5 years in Casablanca, Morocco
BMC Genomics (2021)